An inverse agonist of orphan receptor GPR61 reveals a novel allosteric mechanism
Joshua A. Lees(Pfizer (United States)), Seungil Han(Pfizer (United States))
Cited by 0
Related Papers
Crystal Structure of the Biphenyl-Cleaving Extradiol Dioxygenase from a PCB-Degrading Pseudomonad
|Science|1995|299
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression
|ACS Central Science|2021|63
An inverse agonist of orphan receptor GPR61 acts by a G protein-competitive allosteric mechanism
|Nature Communications|2023|36